Asterion Cannabis Inc. has been featured in a sponsored article published by John McVeigh.
The article covered the federal changes that the Australian government has recently made in regards to licensing for medical cannabis projects. Cannabis projects are now to be given “major project status” to help create more jobs and develop the industry. Asterion’s Toowoomba facility is one of the projects that is being re-prioritized.
Federal Member for Groom John McVeigh said, ” Toowoomba has the perfect mix of climate, transport and logistics support, and research and development capacity to support the Asterion medicinal cannabis project. This significant project is expected to create 800 full-time jobs and 300 part-time, including jobs for scientists undertaking advanced research in both medicine and horticulture. I have been very pleased to work with representatives of Asterion to help advocate for this important project and reiterate the significance of this development for or region and for rural Australia.”
“It is a great step forward and I am very pleased that the Commonwealth Government has acknowledged the importance of the Asterion project to the Australian economy. This significant project will help generate $1 billion in exports of medicinal cannabis around the world, as well as support new jobs and opportunities in regional Australia,” said Asterion CEO and Chair Stephen Van Deventer.
To read the full article, click here.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).